https://biologics.unibiointelligence.com/ weekly 1.0 https://biologics.unibiointelligence.com/tools weekly 0.9 https://biologics.unibiointelligence.com/tools/abnumber monthly 0.8 https://biologics.unibiointelligence.com/modeling weekly 0.9 https://biologics.unibiointelligence.com/visualizers/therapeutic-antibody-dashboard weekly 0.8 https://biologics.unibiointelligence.com/modeling/models/agrawal-2016-nivolumab-dose-selection-er-tgd monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/asiimwe-2025-adc-mbma-cui-poppk monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/besbassi-2026-crs-qsp-locked-cytokine-network monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/briggs-2023-dupilumab-ad-er-pkpd monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/chang-2025-charged-trastuzumab-adc-mice-pkpd monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/cheng-2022-skb264-trop2-adc-preclinical-pkpd monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/chetty-2014-efalizumab-fcrn-pbpk-pd monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/choules-2024-enfortumab-vedotin-adc-pbpk-ddi monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/clegg-2024-azd7442-tixagevimab-cilgavimab-poppk monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/coto-segura-2023-certolizumab-pegol-psoriasis-qsp monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/cui-2024-envafolimab-sc-pdl1-midd monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/de-vries-2018-mcla128-zenocutuzumab-pkpd monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/eaton-2025-dabigatran-idarucizumab-sheep-cpb-pkpd monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/eaton-2025-idarucizumab-dabigatran-sheep-pkpd monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/frank-2023-sutimlimab-cad-pkpd monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/freshwater-2017-pembrolizumab-dosing-strategy-poppk monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/garrett-2019-inotuzumab-ozogamicin-poppk monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/gu-2017-bay1093884-tfpi-qss-tmdd monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/haid-2023-protac-mechanistic-pd-framework monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/jafarnejad-2019-nivolumab-neoadjuvant-pd1-nsclc-qsp monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/lee-2023-atc161-autotac-alpha-syn-pkpd monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/lee-2024-sb12-eculizumab-biosimilar-poppkpd monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/liu-2026-aav-mab-targetx-rat-brain-full-qsp monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/liu-2026-aav-mab-targetx-rat-brain-reduced-qsp monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/lobet-2026-panitumumab-body-composition-poppk monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/markovic-2024-vedolizumab-clearance-remission-poppk monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/monteleone-2021-eculizumab-gmg-pkpd monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/ortiz-2024-ravulizumab-nmosd-pkpd monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/pan-2020-pediatric-tp-pbpk-pk-sim monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/panoilia-2015-bevacizumab-vegf165-qss-tmdd monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/pouliquen-2015-mepolizumab-eosinophil-pkpd monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/prybylski-2026-dazukibart-ifnb-dm-er monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/quartino-2017-pertuzumab-neoadjuvant-pk-er monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/rodriguez-fernandez-2024-secukinumab-psoriasis-mipd monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/serkland-2025-rituximab-ms-pkpd monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/shemesh-2019-atezolizumab-pediatric-poppk-safety monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/stathis-2018-imgn529-cd37-adc-phase1-nca monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/sule-2025-bevacizumab-minimal-pbpk-pediatric-bridge monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/vu-2017-erenumab-cidbf-pkpd-tmdd monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/yagishita-2024-atezolizumab-jtail-real-world-pk monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/yang-2021-cemiplimab-advanced-malignancies-poppk monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/yoshida-2020-crenezumab-abeta-tmdd-pkpd monthly 0.8 https://biologics.unibiointelligence.com/modeling/models/zeng-2026-atezolizumab-software-poppk-simulation monthly 0.8